This report discusses market dynamics, drivers, resistors and future outlook of CMO industry in China. It also includes manufacturing capabilities, growth strategies, SWOT analysis of the top 10 CMOs. Other leading players are also examined.
Features and benefits
* Analyze the competitive positioning and outlook of the leading Chinese CMOs.* Assess the projected growth of the CMO market in China.* Understand the drivers and resistors of contract manufacturing market in China.* Discover contract manufacturing deals that are shaping the development of the market.* Evaluate the potential growth of contract bio-manufacturing in China.
Highlights
China has emerged as one of the leading cost-competitive and quality manufacturing hubs for many multinationals including big pharma companies. Rising cost pressures compounded with economic crisis have continued to drive pharmaceutical companies to seek the cost advantages offered by Chinese CMOs.Developing finished dose exports to developed markets and gaining strength in higher margin services such as high-potency APIs and biologics will be key strategies for Chinese CMOs to overcome intense competition.The drivers of Chinese CMO market include the country’s extensive scientific talent pool, and low cost of labor and raw materials. Concerns over intellectual property and product quality as well as competition from other emerging nations are the key market resistors.
Your key questions answered
* How is the contract manufacturing market evolving globally and in China?* What are the growth strategies of Chinese CMOs such as WuXi AppTec, Shandong Xinhua, Zhejiang Hisun, Zhejiang Huahai, and Chongqing Huapont?* Which Chinese CMOs plan to offer contract bio-manufacturing services?* Which Chinese CMOs have well developed R&D capabilities?* How are growth strategies of Chinese CMOs such as WuXi AppTec, Shandong Xinhua, Zhejiang Hisun, Zhejiang Huahai, and Chongqing Huapont evolving?
Executive Summary
Industry overview
Asymchem Laboratories
Beijing Second Pharmaceutical
Chongqing Huapont Pharmaceutical
Porton Fine Chemicals
Shandong Xinhua Pharmaceutical
Tianjin Pharmaceutical
Venturepharm Laboratories
WuXi AppTec
Zhejiang Hisun Pharma
Zhejiang Huahai Pharmaceutical
Other Key Players
About the author
Disclaimer
Scope and methodology
Scope
Methodology
Industry overview
Summary
Introduction
Overview of the global pharmaceutical contract manufacturing industry
Contract bio-manufacturing is a major opportunity
Key success factors for CMOs
Contract manufacturing industry in Asia
Contract manufacturing industry in China
China’s regulatory framework
Intellectual property protection impacting Chinese CMO industry
API versus finished dose supply
Contract bio-manufacturing in China
Market dynamics
Asymchem Laboratories
Summary
Company overview
Business segmentation
Manufacturing capabilities
Financial performance
Growth strategies
SWOT analysis
Beijing Second Pharmaceutical
Summary
Company Overview
Business segmentation
Manufacturing capabilities
Financial performance
Growth strategies
SWOT analysis
Chongqing Huapont Pharmaceutical
Summary
Company overview
Business segmentation
Manufacturing capabilities
Financial performance
Growth strategies
SWOT analysis
Porton Fine Chemicals
Summary
Company overview
Business segmentation
Manufacturing capabilities
Financial performance
Growth strategy
SWOT analysis
Shandong Xinhua Pharmaceutical
Summary
Company overview
Business segmentation
Manufacturing capabilities
Financial performance
Growth strategies
SWOT analysis
Tianjin Pharmaceutical
Summary
Company overview
Business segments
Manufacturing capability
Financial performance
Growth strategies
SWOT analysis
Venturepharm Laboratories
Summary
Company overview
Business segmentation
Manufacturing capabilities
Financial performance
Growth strategies
SWOT analysis
WuXi AppTec
Summary
Company overview
Business segmentation
Manufacturing capabilities
Financial performance
Growth strategies
SWOT analysis
Zhejiang Hisun Pharma
Summary
Company overview
Business segmentation
Manufacturing capabilities
Financial performance
Growth strategies
SWOT analysis
Zhejiang Huahai Pharmaceutical
Summary
Company Overview
Business segmentation
Manufacturing capabilities
Financial performance
Growth strategies
SWOT analysis
Other key players
Summary
Shanghai Pharmaceutical Group
Harbin Pharmaceutical Group
ShangPharma
Ningbo Dahongying Pharmaceutical
Longchem Co.
Appendix
Glossary
Other selected research from the 'China' category:
Pharmaceuticals: China Industry Guide
The Top 10 CMOs in China
Other selected research from the 'R&D' category:
B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2012
The Top 10 CMOs in India: Market dynamics, competitive positioning and trends